.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Chinese Patent Office
Baxter
Deloitte
Federal Trade Commission
Mallinckrodt
Express Scripts
Boehringer Ingelheim
McKesson
Healthtrust

Generated: December 13, 2017

DrugPatentWatch Database Preview

Natalizumab - Biologic Drug Details

« Back to Dashboard

Summary for Generic Name: natalizumab

Tradenames:1
Patents:108
Applicants:1
BLAs:1
Suppliers: see list1

Pharmacology for Drug: natalizumab

Mechanism of ActionIntegrin Receptor Antagonists
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Inventors Patent Expiration Status Orphan Source
Biogen IdecTYSABRInatalizumabVIAL; SINGLE-USE1251040012004-11-23► Subscribe The Scripps Research Institute (La Jolla, CA) IRM LLC (Hamilton, BM) Schultz; Peter (La Jolla, CA), Lairson; Luke (San Diego, CA), Deshmukh; Vishal (La Jolla, CA), Lyssiotis; Costas (Boston, MA) ► SubscribeRXsearch
Biogen IdecTYSABRInatalizumabVIAL; SINGLE-USE1251040012004-11-23► Subscribe Zymeworks Inc. (Vancouver, CA) Spreter Von Kreudenstein; Thomas (Vancouver, CA), Dixit; Surjit Bhimarao (Richmond, CA), Escobar-Cabrera; Eric (Burnaby, CA), Lario; Paula Irene (Vancouver, CA), Poon; David Kai Yuen (Richmond, CA) ► SubscribeRXsearch
Biogen IdecTYSABRInatalizumabVIAL; SINGLE-USE1251040012004-11-23► Subscribe BIOGEN MA INC. (Cambridge, MA) Maloney; Kevin (Nashua, NH) ► SubscribeRXsearch
Biogen IdecTYSABRInatalizumabVIAL; SINGLE-USE1251040012004-11-23► Subscribe The Trustees of the University of Pennsylvania (Philadelphia, PA) June; Carl H. (Merion Station, PA), Levine; Bruce L. (Cherry Hill, NJ), Porter; David L. (Springfield, PA), Kalos; Michael D. (Philadelphia, PA), Milone; Michael C. (Cherry Hill, NJ) ► SubscribeRXsearch
Biogen IdecTYSABRInatalizumabVIAL; SINGLE-USE1251040012004-11-23► Subscribe TXCELL (Valbonne, FR) Foussat; Arnaud (Biot, FR) ► SubscribeRXsearch
Biogen IdecTYSABRInatalizumabVIAL; SINGLE-USE1251040012004-11-23► Subscribe PROBIODRUG AG (Halle (Saale), DE) Heiser; Ulrich (Halle/Saale, DE), Buchholz; Mirko (Halle/Saale, DE), Sommer; Robert (Magdeburg, DE), Meyer; Antje (Halle/Saale, DE), Demuth; Hans-Ulrich (Halle/Saale, DE) ► SubscribeRXsearch
Biogen IdecTYSABRInatalizumabVIAL; SINGLE-USE1251040012004-11-23► Subscribe PROBIODRUG AG (Halle (Saale), DE) Buchholz; Mirko (Halle/Saale, DE), Heiser; Ulrich (Halle/Saale, DE), Niestroj; Andre J. (Sennewitz, DE) ► SubscribeRXsearch
Biogen IdecTYSABRInatalizumabVIAL; SINGLE-USE1251040012004-11-23► Subscribe Tarix Pharmaceuticals Ltd. (Cambridge, MA) Franklin; Richard (Cambridge, MA) ► SubscribeRXsearch
Biogen IdecTYSABRInatalizumabVIAL; SINGLE-USE1251040012004-11-23► Subscribe Nestec S.A. (Vevey, CH) Singh; Sharat (Rancho Santa Fe, CA), Wang; Shui Long (San Diego, CA), Ohrmund; Linda (San Diego, CA) ► SubscribeRXsearch
Biogen IdecTYSABRInatalizumabVIAL; SINGLE-USE1251040012004-11-23► Subscribe Biogen Inc. (Cambridge, MA) Lieberburg; Ivan (Berkeley, CA) ► SubscribeRXsearch
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
US Army
Cerilliant
QuintilesIMS
AstraZeneca
McKesson
Fish and Richardson
Baxter
Argus Health
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot